Mavacamten in hypertrophic obstructive cardiomyopathy with hepato-renal comorbidities: A case report
This case highlights the complexity of managing HOCM with multiorgan comorbidities, emphasizing the role of novel therapies (e.g., mavacamten) in refractory outflow obstruction and the need for tailored multidisciplinary approaches.
Authors
- Liping Ma
- Sophia Dong
- Fengqin Li
- Rongrong Li
Institutions
- Texas College (US)
- Zhejiang Shuren University (CN)
- Texas A&M University (US)
Publication Details
- Journal
- Medicine
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1097/md.0000000000046935
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00